CNP
44
8
LYB
37
12
FCX
65
6
STZ
50
7
EXPE
74
2
HCA
50
2
DG
29
2
WHR
64
3
LEN
52
4
BK
66
-3
ESS
51
4
MNST
65
5
ADP
65
4
LLY
37
-2
MU
35
3
EMR
50
2
VNO
52
-8
KHC
22
-3
GLW
48
-4
ADI
47
-2
CNP
44
8
LYB
37
12
FCX
65
6
STZ
50
7
EXPE
74
2
HCA
50
2
DG
29
2
WHR
64
3
LEN
52
4
BK
66
-3
ESS
51
4
MNST
65
5
ADP
65
4
LLY
37
-2
MU
35
3
EMR
50
2
VNO
52
-8
KHC
22
-3
GLW
48
-4
ADI
47
-2
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
41

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
61.97
Seasonality Move:
14.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 26.3% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $61.89. The Score for BIB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 26.3% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
41
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
40.54

Prediction Charts

Market Cap:
0
Price in USD:
61.89
Volume:
11.23K
Beta:
1.83

Technical Analysis

SMA50:
64.06
SMA100:
63.51
SMA200:
59.77
52-Wk Change:
35.37%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 61.89 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 64.89 65.66 66.09 64.89
Oct-17 65.81 65.15 65.81 65.08
Oct-18 64.65 65.21 65.50 64.38
Oct-21 64.93 63.32 64.99 62.94
Oct-22 62.48 63.48 63.50 62.10
Oct-23 62.72 61.94 62.72 61.29
Oct-24 62.00 61.73 62.77 61.52
Oct-25 62.17 61.85 62.89 61.72
Oct-28 62.94 63.13 63.70 62.72
Oct-29 63.09 62.71 63.23 62.29
Oct-30 62.82 62.10 63.01 61.68
Oct-31 61.02 60.16 61.05 60.16
Nov-1 60.38 61.67 61.67 60.38
Nov-4 62.22 61.89 62.46 61.15

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.